The US Food and Drug Administration (FDA) will act more swiftly and aggressively to mitigate public health threats under a tough new enforcement agenda outlined in August by Margaret A. Hamburg, MD, the agency's new commissioner.
Hamburg explained that despite efforts of dedicated career staff at the FDA, enforcement actions have been bogged down by arduous processes at the agency (http://www.fda.gov/NewsEvents/Speeches/ucm175983.htm). The result has been unacceptable delays in actions to protect the public health, she said.
Kuehn BM. FDA Boosts Enforcement. JAMA. 2009;302(11):1162. doi:10.1001/jama.2009.1316